Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-07-10 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-04-27 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
ASLN | ASLAN Pharmaceuticals | 3.15 | 0.10 | 3.28% | 211M |
You can purchase shares of ASLAN Pharmaceuticals (NASDAQ: ASLN) through any online brokerage.
Other companies in ASLAN Pharmaceuticals’s space includes: Voyager Therapeutics (NASDAQ:VYGR), T2 Biosystems (NASDAQ:TTOO) and Larimar Therapeutics (NASDAQ:LRMR).
The latest price target for ASLAN Pharmaceuticals (NASDAQ: ASLN) was reported by HC Wainwright & Co. on 2021-03-17. The analyst firm set a price target for 8.00 expecting ASLN to rise to within 12 months (a possible 153.97% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ASLAN Pharmaceuticals (NASDAQ: ASLN) is $3.15 last updated Wed Apr 14 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for ASLAN Pharmaceuticals.
There is no upcoming split for ASLAN Pharmaceuticals.